We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

This FTSE 100 share keeps growing its dividend. I’d buy!

Christopher Ruane owns shares in this FTSE 100 business with a long track record of regular dividend increases. He’d happily buy more today.

| More on:
A pastel colored growing graph with rising rocket.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

One of the things I like about investing in FTSE 100 companies is the income prospects they offer me.

This month, a FTSE 100 share in my portfolio raised its annual dividend 6.5%. Not only that, but this was the 29th year in a row the annual payout had grown. Yet its share price today is substantially cheaper than it was five years ago!

Should you buy Dcc Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

If I had spare money to invest today, I would happily snap up more of its shares for my portfolio.

Serial dividend raiser

The company in question is DCC (LSE: DCC). The name might not be familiar despite the business being a FTSE 100 enterprise.

It has a conglomerate structure, meaning it operates under a variety of different brands. Many of these are in its energy business. DCC is one of the leading suppliers of bottled gas in multiple markets. But it also operates a healthcare business and is active in the technology field.

Energy represents the lion’s share of DCC’s business. Last year, the division accounted for 70% of the company’s total adjusted operating profits of £656m.

Given the high energy prices seen last year, its strong performance came as no surprise. But does its focus on energy involve the risk of a dividend cut as gas prices fall?

Strong business model

I do see a risk. After all, no dividend is ever guaranteed – and past performance is not necessarily an indicator of future success.

Still, DCC’s business model has been proven over decades, including multiple energy market cycles.

Last year’s dividend of £1.87 per share was more than covered by earnings. Adjusted earnings were £4.56 per share, while basic earnings came in at £3.38 per share.

On a free cash flow basis too, the dividend was comfortably covered. Free cash flow for the year came in at £570m. Paying dividends cost the FTSE 100 firm the far smaller sum of £178m.

With that sort of coverage, I reckon DCC could continue its long streak of annual dividend increases, even if earnings fall.

Risk environment

I do have some concerns about future earnings, as it happens. Debt has grown sharply. Net debt jumped 47% last year to £1.1bn. That figure includes lease creditors, but I still think the rapid growth in debt is a risk to profits, especially in a time of rising interest rates.

The flipside is that the company has been incurring debt to fund acquisitions. That could boost earnings potential this year and beyond.

The healthcare division has also been performing weakly, with operating profits falling 8.6% last year.  But that might be due to a customer stock overhang. Once that has worked through the system, hopefully revenue growth will return. But that could take time.

I’d buy!

Despite these risks, I think the company is well-positioned and benefits from a simple but proven business model.

DCC is throwing off large free cash flows. I expect that to continue even in an environment of lower energy prices. Its bottled gas businesses often benefit from a captive market, with few sizeable competitors.

Such free cash flows can help support the dividend. As one of the FTSE 100’s Dividend Aristocrats, I like the long-term income prospects offered by holding DCC shares in my portfolio.

C Ruane has positions in Dcc Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »